Eckert & Ziegler acquires Vitalea Science Inc. as Part of Strategic Move into Innovative Pharmaceutical Services
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its Californian subsidiary Eckert & Ziegler Isotope Products, Inc., has entered into a definite agreement with Vitalea Science, Inc. for the purchase of all of its stock and assets.
Vitalea Science is a pioneering Bioanalytical Contract Research Organization that provides services to researchers and clinicians in drug development supported by validated Accelerator Mass Spectrometry (AMS) technologies. This method is used in pre-clinic and clinic studies for exploring the behavior of drug candidates in the organism. Due to the AMS device’s ultra-sensitivity it is able to detect C14 tagged molecules in microdose levels. Vitalea also provides AMS services for the characterization and identification of non-medical carbon based compounds.
Vitalea’s scientists include the original developers of AMS technology for applied bioscience at its location in Davis, California near the University of California Davis campus, a leading center for research into AMS, PET tracers and other early phase medical studies.
Other news from the department business & finance
